< Back to previous page
Project
PPP2R1A as a new biomarker in type-II endometrial cancers.
The overall goal is the improvement of the current, completely unsatisfying treatment of women with serous endometrial cancer (EC), a cancer in which there is very little interest from the pharmaceutical industry.
Date:1 Jan 2021 → Today
Keywords:endometrial cancer, PPP2R1A, biomarker
Disciplines:Cancer diagnosis, Cancer therapy